Patent details
EP2651400 Title: CONTROLLED RELEASE ORAL DOSAGE FORMS OF POORLY SOLUBLE DRUGS AND USES THEREOF
Basic Information
- Publication number:
- EP2651400
- PCT Application Number:
- US2011065151
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP118318054
- PCT Publication Number:
- WO2012083017
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- CONTROLLED RELEASE ORAL DOSAGE FORMS OF POORLY SOLUBLE DRUGS AND USES THEREOF
- French Title of Invention:
- FORMES POSOLOGIQUES POUR DES MÉDICAMENTS PEU SOLUBLES ADMINISTRÉS PAR VOIE ORALE À LIBÉRATION CONTRÔLÉE ET LEURS UTILISATIONS
- German Title of Invention:
- ORALE RETARD-DARREICHUNGSFORMEN VON SCHWER LÖSLICHEN ARZNEIMITTELN UND IHRE VERWENDUNG
- SPC Number:
Dates
- Filing date:
- 15/12/2011
- Grant date:
- 07/08/2019
- EP Publication Date:
- 23/10/2013
- PCT Publication Date:
- 21/06/2012
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 07/08/2019
- EP B1 Publication Date:
- 07/08/2019
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 15/12/2019
- Expiration date:
- 15/12/2031
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 11/09/2020
- Name:
- Amgen (Europe) GmbH
- Address:
- Floor 6-8 Suurstoffi 22, 6343 Risch-Rotkreuz, Switzerland (CH)
History of Owners
- From:
- 08/05/2020
- To:
- 11/09/2020
- Name:
- Amgen (Europe) GmbH
- Address:
- Floor 6-8 Suurstoffi 22, 6343 Risch-Rotkreuz, Switzerland (CH)
- From:
- 31/07/2019
- To:
- 08/05/2020
- Name:
- Celgene Corporation
- Address:
- 86 Morris Avenue, Summit, NJ 07901, United States (US)
Inventor
1
- Name:
- CHEN, Ming, J.
- Address:
- United States (US)
2
- Name:
- SHEN, Xiaole
- Address:
- United States (US)
3
- Name:
- HUI, Ho-Wah
- Address:
- United States (US)
Priority
- Priority Number:
- 424003 P
- Priority Date:
- 16/12/2010
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 9/22; A61K 9/24; A61K 31/4035;
Publication
Bulletin
- Bulletin Heading:
- CO
- Bulletin edition number:
- 2020/07
- Publication date:
- 12/06/2020
- Description:
- Section M : Transfers of property (Art. 53 of the law), change of name and/or address
European Patent Bulletin
1
- Issue number:
- 201932
- Publication date:
- 07/08/2019
- Description:
- Grant (B1)
2
- Issue number:
- 202024
- Publication date:
- 10/06/2020
- Description:
- Opposition procedure started
3
- Issue number:
- 202042
- Publication date:
- 14/10/2020
- Description:
- Transfer of Rights
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Change of ownership
- Deed Number:
- RC20200000144A
- Date Registered:
- 08/05/2020
- Licence Effective Date:
- Licence Expiration Date:
- Scope of Licence:
- Deed Filer:
- OFFICE FREYLINGER S.A.
- Journal Edition Number:
- Text:
- Country Code:
- Updated Licence Number:
- Terminated Licence Number:
Added Owner(s)
- Name:
- Amgen (Europe) GmbH
- Address:
- Floor 6-8 Suurstoffi 22, 6343 Risch-Rotkreuz, Switzerland (CH)
Removed Pledgee
- Name:
- Address:
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|---|---|
| 25/05/2020 | Outgoing Correspondence | 2 |
| 08/05/2020 | Request For Change | 114 |